Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Betamethasone dipropionate/calcipotriol - MC2 Therapeutics

Next Previous
X
Search
Drug Profile

Betamethasone dipropionate/calcipotriol - MC2 Therapeutics

Alternative Names: BDP/calcipotriene - MC2 Therapeutics; CAL/BDP - MC2 Therapeutics; Calcipotriol/betamethasone dipropionate - MC2 Therapeutics; MC2 01; MC2-01 PAD™ Cream - MC2 Therapeutics; MC2-14; PADcombo - MC2 Therapeutics; PADscalp - MC2 Therapeutics; Winxory; Wynzora

Latest Information Update: 25 Nov 2024

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Drug Delivery Solutions ApS
  • Developer Almirall S.A.; MC2 Therapeutics
  • Class Anti-inflammatories; Antiallergics; Antipsoriatics; Cyclohexenes; Dihydroxycholecalciferols; Fluorinated steroids; Glucocorticoids; Indenes; Small molecules; Vitamin D analogues
  • Mechanism of Action Calcitriol receptor agonists; Interleukin 17 modulators; Interleukin 23 modulators; Steroid receptor agonists; Tumor necrosis factor-alpha expression modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Plaque psoriasis
  • Discontinued Psoriasis

Most Recent Events

  • 15 Nov 2024 Betamethasone dipropionate/calcipotriol licensed to Paladin Pharma in Canada
  • 13 Mar 2024 Hyphens Pharma in-licenses betamethasone dipropionate/calcipotriol from MC2 Therapeutics for Plaque psoriasis in ASEAN countries
  • 09 Nov 2023 Launched for Plaque psoriasis in Italy (Topical) prior to November 2023

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top